Patents Assigned to Unimed Pharmaceuticals, Inc.
  • Dronabinol Treatment for Migraines
    Publication number: 20110155130
    Abstract: In various embodiments, the present invention provides pharmaceutical compositions comprising delta-9-tetrahydrocannabinol and methods of administering such compositions to treat migraines.
    Type: Application
    Filed: March 10, 2011
    Publication date: June 30, 2011
    Applicant: Unimed Pharmaceuticals, Inc.
    Inventor: Lou Barbato
  • Delta-9-THC compositions and methods for treating symptoms associated with multiple sclerosis
    Publication number: 20060167084
    Abstract: Methods are provided for, inter alia, treating and/or preventing symptoms associated with multiple sclerosis and MS relapse.
    Type: Application
    Filed: September 16, 2005
    Publication date: July 27, 2006
    Applicant: Unimed Pharmaceuticals, Inc.
    Inventor: Robert Dudley
  • Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol and semiaqueous solvent therefor
    Patent number: 6747058
    Abstract: A formulation of delta-9-tetrahydrocannabinol in a semi-aqueous solvent, such as 35:10:55 alcohol:water:propylene glycol (v/v), produces a stable clear solution near the solubility point of the drug. Because delta-9-tetrahydrocannabinol has poor affinity for the formulation, it is able to partition out and transport across cell membranes to reach the bloodstream quickly. This has been demonstrated by the comparative tmax values achieved in single dose intravenous and 14 day multiple dose inhalation studies conducted in dogs and rats.
    Type: Grant
    Filed: August 15, 2000
    Date of Patent: June 8, 2004
    Assignee: Unimed Pharmaceuticals, Inc.
    Inventors: Mahendra G. Dedhiya, Julia J. Economou, Andrea M. McPhillips, Beverley A. Wynne
  • Appetite stimulation and induction of weight gain in patients suffering from symptomatic HIV infection
    Patent number: 6703418
    Abstract: Patients with symptomatic HIV infection, including AIDS and ARC are treated to increase appetite and to cause a reduction in loss of weight. The delta-9-tetrahydrocannabinol may be administered orally, in capsules, or in tablets, or by injection, suppository, intranasal, transdermal, inhalant or sublingual administration.
    Type: Grant
    Filed: June 3, 1992
    Date of Patent: March 9, 2004
    Assignee: Unimed Pharmaceuticals, Inc.
    Inventor: Terry Plasse
  • Pharmaceutical composition and method for treating hypogonadism
    Patent number: 6503894
    Abstract: A pharmaceutical composition useful for treating hypogonadism is disclosed. The composition comprises an androgenic or anabolic steroid, a C1-C4 alcohol, a penetration enhancer such as isopropyl myristate, and water. Also disclosed is a method for treating hypogonadism utilizing the composition.
    Type: Grant
    Filed: August 30, 2000
    Date of Patent: January 7, 2003
    Assignees: Unimed Pharmaceuticals, Inc., Laboratories Besins Iscovesco
    Inventors: Robert E. Dudley, S. George Kottayil, Olivier Palatchi
  • Method for improving disturbed behavior and elevating mood in humans
    Patent number: 5804592
    Abstract: A method for improving disturbed behavior and negative mood in animals suffering from dementia, particularly humans suffering from Alzheimer's type dementia, by administration of dronabinol.
    Type: Grant
    Filed: May 30, 1997
    Date of Patent: September 8, 1998
    Assignee: Unimed Pharmaceuticals, Inc.
    Inventor: Ladislav Volicer